DINAQOR
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure. Its lead preclinical program, DiNA-001, is focused on the treatment of MYBPC3-linked cardiomyopathy. DiNAQOR was founded in 2019 and is headquartered in Pfäffikon, Switzerland.
DINAQOR
Industry:
Biotechnology Health Care Medical
Founded:
2019-04-01
Address:
Pfäffikon, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.dinaqor.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Activaero
Activaero develops breathing technologies for patients suffering from severe respiratory diseases.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
FABPulous
FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-19 | EHT Technologies | EHT Technologies acquired by DiNAQOR | N/A |
Official Site Inspections
http://www.dinaqor.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: summer.metanet.ch
- IP address: 80.74.149.100
- Location: Neunkirch Switzerland
- Latitude: 47.6901
- Longitude: 8.4998
- Timezone: Europe/Zurich
- Postal: 8213
